ℹ️ For more info and details: https://t.co/GAi6Q0XOka https://t.co/JpnsSmbVwN https://t.co/fw5QWVWWFM
RT @STriTuVaD: A study from the NIH shows no significant benefit of convalescent plasma for #covid19 outpatients with early symptoms: inter…
RT @STriTuVaD: A study from the NIH shows no significant benefit of convalescent plasma for #covid19 outpatients with early symptoms: inter…
A study from the NIH shows no significant benefit of convalescent plasma for #covid19 outpatients with early symptoms: interesting thing is we obtained the same results with #insilico methodologies already in December. Read the article on @BMCBioinfo https
A new large study confirms no significant benefit of hyperimmune plasma therapy for COVID-19 patients. https://t.co/X6BS5IYF6p The #combinegroup predicted this outcome months before. Another success story of in #insilicotrials. Link to article: https://t.c
RT @BioMedCentral: In an article published in BMC Bioinformatics, researchers present 'Universal Immune System Simulator': an in silico tri…
RT @BioMedCentral: In an article published in BMC Bioinformatics, researchers present 'Universal Immune System Simulator': an in silico tri…
RT @BioMedCentral: In an article published in BMC Bioinformatics, researchers present 'Universal Immune System Simulator': an in silico tri…
In an article published in BMC Bioinformatics, researchers present 'Universal Immune System Simulator': an in silico trial platform to speed-up and drive the discovery pipeline of vaccines against SARS-CoV-2. https://t.co/RYRI4n2WO9
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform https://t.co/JpnsSmbVwN #BMCBioinformatics #COMBINEGroup #insilico #insilicotrials #insilicomedicine #papers
RT @STriTuVaD: UISS has been extended to be used as an in silico trial platform to speed-up and drive the discovery pipeline of vaccine aga…
RT @STriTuVaD: UISS has been extended to be used as an in silico trial platform to speed-up and drive the discovery pipeline of vaccine aga…
RT @STriTuVaD: UISS has been extended to be used as an in silico trial platform to speed-up and drive the discovery pipeline of vaccine aga…
RT @STriTuVaD: UISS has been extended to be used as an in silico trial platform to speed-up and drive the discovery pipeline of vaccine aga…
UISS has been extended to be used as an in silico trial platform to speed-up and drive the discovery pipeline of vaccine against SARS-CoV-2: read more on our paper on @BioMedCentral https://t.co/9KHmoomwFp @COMBINE_Group @unict_it @UniboMagazine @EU_EASM